CME Group (NASDAQ:CME) Downgraded to “Strong Sell” at BidaskClub

BidaskClub downgraded shares of CME Group (NASDAQ:CME) from a sell rating to a strong sell rating in a research report report published on Wednesday morning, BidAskClub reports.

CME has been the topic of several other research reports. Wells Fargo & Company cut their price target on CME Group from $186.00 to $176.00 in a research note on Monday, July 6th. Atlantic Securities upgraded CME Group from a neutral rating to an overweight rating and boosted their price target for the stock from $176.00 to $195.00 in a research note on Wednesday, September 23rd. Zacks Investment Research upgraded CME Group from a sell rating to a hold rating and set a $175.00 price objective on the stock in a research note on Tuesday, September 29th. Rosenblatt Securities upped their price objective on CME Group from $138.00 to $141.00 and gave the company a sell rating in a research note on Monday, October 5th. Finally, Oppenheimer restated a buy rating on shares of CME Group in a research note on Wednesday, July 29th. Five equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and seven have given a buy rating to the company’s stock. CME Group presently has a consensus rating of Hold and an average price target of $182.94.

Shares of NASDAQ CME opened at $149.56 on Wednesday. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. CME Group has a 1-year low of $131.80 and a 1-year high of $225.36. The business has a 50-day moving average of $166.69 and a 200-day moving average of $173.12. The company has a market capitalization of $53.64 billion, a price-to-earnings ratio of 22.56, a PEG ratio of 5.09 and a beta of 0.32.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Wednesday, October 28th. The financial services provider reported $1.38 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $1.41 by ($0.03). CME Group had a return on equity of 9.93% and a net margin of 46.39%. During the same period last year, the firm posted $1.90 earnings per share. Research analysts expect that CME Group will post 6.87 EPS for the current fiscal year.

In other news, Director Dennis Suskind sold 2,000 shares of the firm’s stock in a transaction dated Tuesday, August 25th. The stock was sold at an average price of $174.61, for a total value of $349,220.00. Following the sale, the director now directly owns 3,565 shares of the company’s stock, valued at $622,484.65. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Charles P. Carey sold 8,000 shares of CME Group stock in a transaction dated Tuesday, August 11th. The stock was sold at an average price of $165.39, for a total value of $1,323,120.00. Insiders have sold 15,900 shares of company stock worth $2,695,838 over the last three months. Company insiders own 1.20% of the company’s stock.

A number of hedge funds have recently added to or reduced their stakes in the stock. Trustcore Financial Services LLC lifted its stake in CME Group by 397.1% during the second quarter. Trustcore Financial Services LLC now owns 174 shares of the financial services provider’s stock worth $28,000 after purchasing an additional 139 shares during the period. Tarbox Family Office Inc. lifted its stake in CME Group by 75.5% during the third quarter. Tarbox Family Office Inc. now owns 193 shares of the financial services provider’s stock worth $32,000 after purchasing an additional 83 shares during the period. Alpha Windward LLC bought a new position in CME Group during the second quarter worth about $35,000. CVA Family Office LLC bought a new position in CME Group during the third quarter worth about $38,000. Finally, Financial Management Professionals Inc. bought a new position in CME Group during the second quarter worth about $47,000. 84.24% of the stock is currently owned by institutional investors and hedge funds.

CME Group Company Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

See Also: What does it mean to hold a stock in street name?

Analyst Recommendations for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.